Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


07.12.2015

2 Ann Nucl Med
1 IEEE Trans Med Imaging
3 J Nucl Cardiol
3 Nucl Med Commun
2 Nuklearmedizin
1 Phys Med Biol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Nucl Med

  1. KREMER R, Peysakhovich Y, Dan LF, Guralnik L, et al
    FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available

  2. FALLAHI B, Esmaeili A, Beiki D, Oveisgharan S, et al
    Evaluation of Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    IEEE Trans Med Imaging

  3. YANG L, Wang G, Qi J
    Theoretical analysis of penalized maximum-likelihood Patlak parametric image reconstruction in dynamic PET for lesion detection.
    IEEE Trans Med Imaging. 2015.
    PubMed     Text format     Abstract available


    J Nucl Cardiol

  4. WADA K, Niitsuma T, Yamaki T, Masuda A, et al
    Simultaneous cardiac imaging to detect inflammation and scar tissue with F-fluorodeoxyglucose PET/MRI in cardiac sarcoidosis.
    J Nucl Cardiol. 2015.
    PubMed     Text format    

  5. MILLER EO, Schwartz RG
    Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?
    J Nucl Cardiol. 2015.
    PubMed     Text format    

  6. ANDRIKOPOULOU E, Lloyd SG, Hage FG
    Ventricular tachycardia during regadenoson SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2015.
    PubMed     Text format    


    Nucl Med Commun

  7. FU Z, Liu M, Li Z, Fan Y, et al
    Is the bullhead sign on bone scintigraphy really common in the patient with SAPHO syndrome? A single-center study of a 16-year experience.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available

  8. FERNANDES RS, Silva JO, Lopes SC, Chondrogiannis S, et al
    Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available

  9. OSBORNE DR, Acuff S
    Whole-body dynamic imaging with continuous bed motion PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    Nuklearmedizin

  10. MULLER FH, Farahati J, Muller AG, Gillman E, et al
    Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available

  11. ZHANG Y, Shi H, Li B, Cai L, et al
    The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
    Nuklearmedizin. 2015;54:255-61.
    PubMed     Text format     Abstract available


    Phys Med Biol

  12. FENG T, Wang J, Fung G, Tsui B, et al
    Non-rigid dual respiratory and cardiac motion correction methods after, during, and before image reconstruction for 4D cardiac PET.
    Phys Med Biol. 2015;61:151-168.
    PubMed     Text format     Abstract available


    PLoS One

  13. KORSHOLM K, Feldt-Rasmussen U, Granqvist H, Hojgaard L, et al
    Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up.
    PLoS One. 2015;10:e0143940.
    PubMed     Text format     Abstract available

  14. SALAMON J, Papp L, Toth Z, Laqmani A, et al
    Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT.
    PLoS One. 2015;10:e0143305.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: